High-dose therapy followed by autologous stem cell transplantation emerges as the preferred salvage therapy in patients with limited-stage Hodgkin lymphoma progressing/relapsing after initial therapy: A subset analysis of the EORTC/LYSA/FIL H10 trial

Gotti Manuel; Yana Stepanishyna; Tetiana Skrypets; Luigi Marcheselli; Caterina Cristinelli; Barbara Botto; Sanne Tonino; Doriane Cavalieri; Alessandro Pulsoni; Martin Hutchings; Mohammad Hammoud; Catherine Fortpied; Luigi Rigacci; Wouter Plattel; Marc André; Massimo Federico

doi:10.1002/hem3.70105

High-dose therapy followed by autologous stem cell transplantation emerges as the preferred salvage therapy in patients with limited-stage Hodgkin lymphoma progressing/relapsing after initial therapy: A subset analysis of the EORTC/LYSA/FIL H10 trial

Gotti Manuel, Yana Stepanishyna^*, Tetiana Skrypets, Luigi Marcheselli, Caterina Cristinelli, Barbara Botto, Sanne Tonino, Doriane Cavalieri, Alessandro Pulsoni, Martin Hutchings, Mohammad Hammoud, Catherine Fortpied, Luigi Rigacci, Wouter Plattel, Marc André, Massimo Federico

^*Corresponding author af dette arbejde

Afdeling for Blodsygdomme CKO

Originalsprog	Engelsk
Artikelnummer	e70105
Tidsskrift	HemaSphere
Vol/bind	9
Udgave nummer	4
Sider (fra-til)	e70105
ISSN	2572-9241
DOI	https://doi.org/10.1002/hem3.70105
Status	Udgivet - apr. 2025

Adgang til dokumentet

10.1002/hem3.70105Licens: CC BY

Andre filer og links

Link to publication in Scopus

Citationsformater

Manuel, G., Stepanishyna, Y., Skrypets, T., Marcheselli, L., Cristinelli, C., Botto, B., Tonino, S., Cavalieri, D., Pulsoni, A., Hutchings, M., Hammoud, M., Fortpied, C., Rigacci, L., Plattel, W., André, M., & Federico, M. (2025). High-dose therapy followed by autologous stem cell transplantation emerges as the preferred salvage therapy in patients with limited-stage Hodgkin lymphoma progressing/relapsing after initial therapy: A subset analysis of the EORTC/LYSA/FIL H10 trial. HemaSphere, 9(4), e70105. Artikel e70105. https://doi.org/10.1002/hem3.70105

High-dose therapy followed by autologous stem cell transplantation emerges as the preferred salvage therapy in patients with limited-stage Hodgkin lymphoma progressing/relapsing after initial therapy: A subset analysis of the EORTC/LYSA/FIL H10 trial. / Manuel, Gotti; Stepanishyna, Yana; Skrypets, Tetiana et al.
I: HemaSphere, Bind 9, Nr. 4, e70105, 04.2025, s. e70105.

Publikation: Bidrag til tidsskrift › Letter › peer review

Manuel, G, Stepanishyna, Y, Skrypets, T, Marcheselli, L, Cristinelli, C, Botto, B, Tonino, S, Cavalieri, D, Pulsoni, A, Hutchings, M, Hammoud, M, Fortpied, C, Rigacci, L, Plattel, W, André, M & Federico, M 2025, 'High-dose therapy followed by autologous stem cell transplantation emerges as the preferred salvage therapy in patients with limited-stage Hodgkin lymphoma progressing/relapsing after initial therapy: A subset analysis of the EORTC/LYSA/FIL H10 trial', HemaSphere, bind 9, nr. 4, e70105, s. e70105. https://doi.org/10.1002/hem3.70105

Manuel G, Stepanishyna Y, Skrypets T, Marcheselli L, Cristinelli C, Botto B et al. High-dose therapy followed by autologous stem cell transplantation emerges as the preferred salvage therapy in patients with limited-stage Hodgkin lymphoma progressing/relapsing after initial therapy: A subset analysis of the EORTC/LYSA/FIL H10 trial. HemaSphere. 2025 apr.;9(4):e70105. e70105. doi: 10.1002/hem3.70105

@article{419dcf53afe7492ab839fa7aec0c69b8,

title = "High-dose therapy followed by autologous stem cell transplantation emerges as the preferred salvage therapy in patients with limited-stage Hodgkin lymphoma progressing/relapsing after initial therapy: A subset analysis of the EORTC/LYSA/FIL H10 trial",

author = "Gotti Manuel and Yana Stepanishyna and Tetiana Skrypets and Luigi Marcheselli and Caterina Cristinelli and Barbara Botto and Sanne Tonino and Doriane Cavalieri and Alessandro Pulsoni and Martin Hutchings and Mohammad Hammoud and Catherine Fortpied and Luigi Rigacci and Wouter Plattel and Marc Andr{\'e} and Massimo Federico",

year = "2025",

month = apr,

doi = "10.1002/hem3.70105",

language = "English",

volume = "9",

pages = "e70105",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "John Wiley and Sons Inc.",

number = "4",

}

TY - JOUR

T1 - High-dose therapy followed by autologous stem cell transplantation emerges as the preferred salvage therapy in patients with limited-stage Hodgkin lymphoma progressing/relapsing after initial therapy

T2 - A subset analysis of the EORTC/LYSA/FIL H10 trial

AU - Manuel, Gotti

AU - Stepanishyna, Yana

AU - Skrypets, Tetiana

AU - Marcheselli, Luigi

AU - Cristinelli, Caterina

AU - Botto, Barbara

AU - Tonino, Sanne

AU - Cavalieri, Doriane

AU - Pulsoni, Alessandro

AU - Hutchings, Martin

AU - Hammoud, Mohammad

AU - Fortpied, Catherine

AU - Rigacci, Luigi

AU - Plattel, Wouter

AU - André, Marc

AU - Federico, Massimo

PY - 2025/4

Y1 - 2025/4

UR - http://www.scopus.com/inward/record.url?scp=105002058447&partnerID=8YFLogxK

U2 - 10.1002/hem3.70105

DO - 10.1002/hem3.70105

M3 - Letter

C2 - 40177617

SN - 2572-9241

VL - 9

SP - e70105

JO - HemaSphere

JF - HemaSphere

IS - 4

M1 - e70105

ER -